Arnaud Delobel

Arnaud Delobel is the R&D and Innovation Director at Quality Assistance, with deep expertise in analytical sciences spanning all therapeutic modalities, from monoclonal antibodies and antibody-drug conjugates to mRNA vaccines and cell and gene therapies. He is a recognized expert in the Monoclonal Antibodies Working Party (MAB WP) at the European Directorate for the Quality of Medicines & HealthCare (EDQM) in Strasbourg and regularly contributes to academic discourse through lectures at the University of Strasbourg.

Arnaud graduated from ECPM Strasbourg and earned his PhD in mass spectrometry of proteins and peptides at the CNRS in Gif-sur-Yvette, followed by a postdoctoral fellowship in proteomics in Liège, Belgium. He joined Quality Assistance in 2006 and was appointed Director of R&D and Innovation in 2016.

In this role, Arnaud leads internal R&D projects aimed at integrating cutting-edge analytical technologies, transforming scientific advances into services that address emerging industry and regulatory needs. He also mentors Scientific Advisors in strategic innovation, combining insights from regulatory intelligence, scientific literature, and market analysis.

Arnaud has authored multiple peer-reviewed publications and served as editor of a volume dedicated to the analytical characterisation of biopharmaceuticals in the Methods in Molecular Biology series (Springer Nature, 2022).



Back to our Executive Committee